awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28483929-03A12A35-A2E2-451B-816A-1706296EB61C
Q28483929-03A12A35-A2E2-451B-816A-1706296EB61C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28483929-03A12A35-A2E2-451B-816A-1706296EB61C
Nilotinib counteracts P-glycoprotein-mediated multidrug resistance and synergizes the antitumoral effect of doxorubicin in soft tissue sarcomas
P2860
Q28483929-03A12A35-A2E2-451B-816A-1706296EB61C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28483929-03A12A35-A2E2-451B-816A-1706296EB61C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f4e027077398a38c1e1a39d4dc36c8cc84c0fd09
P2860
Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis.